Actualités Intelgenx Technologies Corp - IGX | Actions TSX Venture Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

SAINT LAURENT, Quebec, Oct. 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”...

IntelGenx Receives Final Approval to Graduate to Toronto Stock Exchange

SAINT LAURENT, Quebec, Oct. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB:...

IntelGenx and Aquestive Therapeutics Partner with Leading Men’s Health Company to Market Tadalafil Oral Films in the U.S.

SAINT LAURENT, Quebec, Sept. 29, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQB:IGXT...

IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange

SAINT LAURENT, Quebec, Sept. 15, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company”) announces that...

IntelGenx Announces Market Launch of RIZAPORT® in Spain

SAINT LAURENT, Quebec, Sept. 07, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the...

IntelGenx Ships CBD Filmstrips to Heritage Cannabis in Support of Canadian Market Launch

SAINT LAURENT, Quebec, Aug. 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced...

IntelGenx Announces Closing of Notes Offering

SAINT LAURENT, Quebec, Aug. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB:...

IntelGenx Reports Second Quarter 2021 Financial Results

SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT...

IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert

SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx...

IntelGenX to Report Second Quarter 2021 Financial Results on August 4, 2021 – Conference Call to Follow

SAINT LAURENT, Quebec, July 29, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX...

IntelGenx Announces Subscription for Notes

SAINT LAURENT, Quebec, July 27, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”...

IntelGenx’s VetaFilm™ Platform to be Evaluated by One of the World’s Fastest Growing Animal Healthcare Companies

SAINT LAURENT, Quebec, June 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT...

IntelGenx Announces Noteholder Approval of Proposed Amendments to Convertible Notes

SAINT LAURENT, Québec, May 19, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX...

IntelGenx Announces Initial Closing of atai Investment

SAINT LAURENT, Quebec, May 14, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT...

IntelGenx Reports First Quarter 2021 Financial Results

SAINT-LAURENT, Quebec, May 13, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intelgenx Technologies Corp (IGX)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

IGX Actualités

Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

IntelGenx Receives Final Approval to Graduate to Toronto Stock Exchange

IntelGenx and Aquestive Therapeutics Partner with Leading Men’s Health Company to Market Tadalafil Oral Films in the U.S.

IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange

IntelGenx Announces Market Launch of RIZAPORT® in Spain

IntelGenx Ships CBD Filmstrips to Heritage Cannabis in Support of Canadian Market Launch

IntelGenx Announces Closing of Notes Offering

IntelGenx Reports Second Quarter 2021 Financial Results

IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert

IntelGenX to Report Second Quarter 2021 Financial Results on August 4, 2021 – Conference Call to Follow

IntelGenx Announces Subscription for Notes

IntelGenx’s VetaFilm™ Platform to be Evaluated by One of the World’s Fastest Growing Animal Healthcare Companies

IntelGenx Announces Noteholder Approval of Proposed Amendments to Convertible Notes

IntelGenx Announces Initial Closing of atai Investment

IntelGenx Reports First Quarter 2021 Financial Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intelgenx Technologies Corp (IGX) Actualités

Intelgenx Technologies Corp (IGX)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

IGX Actualités

Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

IntelGenx Receives Final Approval to Graduate to Toronto Stock Exchange

IntelGenx and Aquestive Therapeutics Partner with Leading Men’s Health Company to Market Tadalafil Oral Films in the U.S.

IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange

IntelGenx Announces Market Launch of RIZAPORT® in Spain

IntelGenx Ships CBD Filmstrips to Heritage Cannabis in Support of Canadian Market Launch

IntelGenx Announces Closing of Notes Offering

IntelGenx Reports Second Quarter 2021 Financial Results

IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert

IntelGenX to Report Second Quarter 2021 Financial Results on August 4, 2021 – Conference Call to Follow

IntelGenx Announces Subscription for Notes

IntelGenx’s VetaFilm™ Platform to be Evaluated by One of the World’s Fastest Growing Animal Healthcare Companies

IntelGenx Announces Noteholder Approval of Proposed Amendments to Convertible Notes

IntelGenx Announces Initial Closing of atai Investment

IntelGenx Reports First Quarter 2021 Financial Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités